Results 251 to 260 of about 376,311 (300)
Some of the next articles are maybe not open access.
Clinics in Liver Disease, 1999
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources
2017
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +2 more sources
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +2 more sources
Vaccine, 1998
Currently available hepatitis B vaccines are immunogenic, efficacious and safe. There is no doubt that their consistent use makes the elimination of hepatitis B in most countries possible. Nevertheless, there are still aspects of these vaccines which could be improved: three doses are needed for a full course of vaccination (which is sometimes ...
openaire +3 more sources
Currently available hepatitis B vaccines are immunogenic, efficacious and safe. There is no doubt that their consistent use makes the elimination of hepatitis B in most countries possible. Nevertheless, there are still aspects of these vaccines which could be improved: three doses are needed for a full course of vaccination (which is sometimes ...
openaire +3 more sources
Safety of hepatitis B vaccines
Travel Medicine and Infectious Disease, 2004Although concerns about vaccine safety have increased, true adverse reactions associated with hepatitis B vaccines are few, apart from minor symptoms at the site of injection and occasionally systemic reactions. There is no evidence of an association with hepatitis B vaccination and Sudden Infant Death Syndrome, Multiple Sclerosis and the Chronic ...
openaire +3 more sources
A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B).
Journal of the American Medical Association (JAMA), 2018semanticscholar +1 more source
SARS-CoV-2 variants, spike mutations and immune escape
Nature Reviews Microbiology, 2021William T Harvey +2 more
exaly
Hepatitis B vaccine nonresponders: Possible mechanisms and solutions.
Annals of Allergy, Asthma & Immunology, 2018T. Saco +2 more
semanticscholar +1 more source
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2022Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
Hepatitis B vaccine response in obesity: A meta-analysis.
Vaccine, 2016W. Fan +4 more
semanticscholar +1 more source